PLAY PODCASTS
Episode 457: The CEO Who Goes Blind in 7 Days Without His Own Cannabis Oils
Episode 457

Episode 457: The CEO Who Goes Blind in 7 Days Without His Own Cannabis Oils

When doctors told Al Morentin there was nothing they could do for his glaucoma, he refused to accept blindness as his fate. In this powerful interview, Al shares how he developed his own Rick Simpson Oil formulation—not only reversing his vision loss but also eliminating chronic migraines and pain. Today, he's the founder of Movida and My Fit Life, helping thousands transition off pharmaceuticals using cannabis medicine. But if Al stops taking his oil for even a week, he goes blind again. His story is one of resilience, innovation, and the life-changing potential of plant medicine.

Cannabis Health Radio Podcast · Al Morentin, Ian Jessop

July 17, 202535m 19s

Audio is streamed directly from the publisher (afp-901980-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

When doctors told Al Morentin there was nothing they could do for his glaucoma, he refused to accept blindness as his fate. In this powerful interview, Al shares how he developed his own Rick Simpson Oil formulation—not only reversing his vision loss but also eliminating chronic migraines and pain. Today, he's the founder of Movida and My Fit Life, helping thousands transition off pharmaceuticals using cannabis medicine. But if Al stops taking his oil for even a week, he goes blind again.

myfitlife.net

YouTube.com/myfitlife

Visit our website: CannabisHealthRadio.com

Find high-quality cannabis and CBD + get free consultations at MyFitLife.net/cannabishealth

Discover products and get expert advice from Swan Apothecary

Follow us on Facebook.

Follow us on Instagram.

Find us on Rumble.

Keep your privacy! Buy NixT420 Odor Remover


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

glaucomaal morentin